PI3K inhibitors for the treatment of endometriosis
OA: closed
AI-generated summary
The patent discloses using a compound of formula (I), or its salt or isomer, as a phosphoinositide 3-kinase inhibitor for the treatment of endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Disclosed is the use of a compound of formula (I), or a salt or isomer thereof, where the substituents are as defined in the specification, as a PI3K inhibitor to treat endometriosis.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-08-10T06:11:17.106188+00:00